GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Biomerica Inc.
Biomerica develops diagnostic tests. Its stock price reflects demand for its products to detect gastrointestinal diseases and other conditions. This chart tells the story of a small MedTech company vying for a share of the competitive diagnostics market.
Share prices of companies in the market segment - Medanalysis
Biomerica produces and sells medical diagnostic tests for gastrointestinal diseases and other conditions. We've classified it as a "Medanalysis" company. The chart below shows how the market values companies operating in the rapid diagnostics sector.
Broad Market Index - GURU.Markets
Biomerica develops and markets diagnostic tests for gastrointestinal and other diseases. Its focus on this niche makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how Biomerica fits into the overall trend.
Change in the price of a company, segment, and market as a whole per day
BMRA - Daily change in the company's share price Biomerica Inc.
For Biomerica, Inc., a medical diagnostics company, daily volatility reflects sensitivity to news about the development and approval of new tests. This metric is an important element of analysis in the MedTech sector.
Daily change in the price of a set of shares in a market segment - Medanalysis
Biomerica develops and markets diagnostic tests for disease detection. The medical diagnostics sector is sensitive to regulatory approvals and competition. The chart below shows the average volatility in this niche, allowing for a comparison of BMRA's price dynamics with other companies in the industry.
Daily change in the price of a broad market stock, index - GURU.Markets
Biomerica is a company specializing in medical diagnostics, including tests for gastrointestinal diseases. The company's shares react to news of its tests being accepted by the medical community. This specific volatility, driven by medical innovation, feeds into the overall market movement.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Biomerica Inc.
Biomerica, Inc.'s year-over-year performance tells the story of its performance in the diagnostic testing market. Its market cap change over the past 12 months reflects demand for its tests for gastrointestinal diseases and other conditions, as well as its progress in developing new products, such as a colon cancer test, which is its main bet for the future.
Annual dynamics of market capitalization of the market segment - Medanalysis
Biomerica, Inc. is a diagnostic testing company. The chart below shows how its diversified portfolio, competition, and dependence on diagnostic demand impact its performance in the medical testing sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Biomerica, a manufacturer of diagnostic tests for gastrointestinal diseases and other conditions, operates in a stable healthcare market. Comparing its annual market capitalization dynamics with the overall market shows how demand for early diagnostics and new products is driving the company's growth, making it less dependent on short-term economic cycles.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Biomerica Inc.
Biomerica is a diagnostic testing company. Its monthly performance reflects sales of its products, particularly tests for gastrointestinal diseases. News about regulatory approvals for new tests or partnerships are key.
Monthly dynamics of market capitalization of the market segment - Medanalysis
Biomerica, Inc. is a global biomedical company that develops, manufactures, and markets advanced diagnostic tests for the early detection of diseases. The dynamics of its sector, shown in the graph, reflect innovation in medicine. Against this backdrop, one can appreciate how its tests for gastrointestinal and other diseases help doctors and patients.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Biomerica produces diagnostic tests for medical institutions and home use. Its stock price is driven by sales volumes and news of new test approvals. The chart shows how the stock reacts to quarterly reports, making it more predictable than that of research-stage biotechs.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Biomerica Inc.
Biomerica, a diagnostic testing maker, is at the center of any healthcare news. Its weekly stock price reflects demand for tests to detect various diseases, regulatory decisions, and general public concern about health and early detection.
Weekly dynamics of market capitalization of the market segment - Medanalysis
Biomerica develops and markets diagnostic tests, including for gastrointestinal diseases. Demand for its products may grow amid increased attention to health. The chart compares the company's weekly performance with the overall state of the medical diagnostics sector and identifies its unique drivers.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Biomerica develops diagnostic tests. Demand for its products is relatively stable, making its shares a safe haven. The chart will help assess whether the company is truly less volatile than the overall market, especially during periods of economic uncertainty.
Market capitalization of the company, segment and market as a whole
BMRA - Market capitalization of the company Biomerica Inc.
Biomerica's market capitalization is a measure of investor valuation of its diagnostic testing business. The chart shows how the market values its products for detecting gastrointestinal diseases and other conditions. Its dynamics reflect its efforts to introduce new tests, including cancer tests, and the competition in this area.
BMRA - Share of the company's market capitalization Biomerica Inc. within the market segment - Medanalysis
Biomerica produces diagnostic tests for gastrointestinal diseases and other conditions. Its market share in the medical technology sector reflects its niche specialization. Its market capitalization reflects the strength of its products, which enable rapid and accurate diagnostics both in laboratories and at home.
Market capitalization of the market segment - Medanalysis
This graph shows the total value of the entire medical diagnostics market. For Biomerica, which produces tests to diagnose gastrointestinal diseases and other conditions, this line represents a health map. The rising graph reflects the growing importance of early and accurate diagnosis for effective treatment, which is the core of the company's business.
Market capitalization of all companies included in a broad market index - GURU.Markets
Biomerica produces diagnostic tests for gastrointestinal diseases and other conditions. Its market capitalization is determined by its early diagnostics business, which represents the market share of businesses that enable early detection of health problems.
Book value capitalization of the company, segment and market as a whole
BMRA - Book value capitalization of the company Biomerica Inc.
Biomerica produces diagnostic tests for healthcare institutions and home use. Its book value is derived from its production facilities, laboratories, patents, and inventory of finished tests. This is the material foundation for rapid and accurate diagnostics. How has its value changed? The chart below shows.
BMRA - Share of the company's book capitalization Biomerica Inc. within the market segment - Medanalysis
Biomerica, Inc. manufactures diagnostic tests. Its business relies on its own FDA-certified manufacturing facilities, which produce tests for gastrointestinal and other diseases. The chart shows the company's share of the physical infrastructure required to produce medical diagnostic kits.
Market segment balance sheet capitalization - Medanalysis
Biomerica is a diagnostics company. Its model is balanced against the backdrop of the capital-intensive healthcare sector. The industry's asset chart reflects the value of hospitals. Biomerica owns the factories that manufacture its diagnostic tests.
Book value of all companies included in the broad market index - GURU.Markets
Biomerica's book value is represented by its production facilities and laboratories for the development and production of diagnostic tests, including those for gastrointestinal diseases and COVID-19. The company's assets reflect its potential for rapid and affordable diagnostics. The chart shows the physical weight of this manufacturer in the medical testing market.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Biomerica Inc.
Biomerica produces diagnostic tests. Its value lies not only in its product lines but also in its portfolio of approved tests, patents, and distribution network. Its market capitalization reflects its role in medical diagnostics and its ability to develop new products.
Market to book capitalization ratio in a market segment - Medanalysis
Biomerica develops and markets diagnostic tests. Its value lies in its technologies and patents. This chart shows how investors evaluate its product portfolio and its ability to bring new tests to market for early disease detection, a key trend in medicine.
Market to book capitalization ratio for the market as a whole
Biomerica develops diagnostic tests. The company's value lies in the precision of its technologies and its ability to quickly bring in-demand products to market. This chart compares the valuation of a company in the medtech sector, where both patents and manufacturing are important, with overall market indicators reflecting investor sentiment.
Debts of the company, segment and market as a whole
BMRA - Company debts Biomerica Inc.
Biomerica, a diagnostic testing company, uses capital to fund R&D, clinical trials to secure FDA approval, and commercial expansion. This chart shows how the company invests in bringing its products to market, a lengthy and expensive process in the medical industry.
Market segment debts - Medanalysis
Biomerica develops and markets diagnostic tests for various diseases, primarily gastrointestinal. This chart illustrates how the company, operating in the competitive medical diagnostics market, manages its capital to fund R&D, obtain regulatory approvals, and bring its products to market through various sales channels.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Biomerica Inc.
Biomerica develops and markets diagnostic tests for various diseases, including gastrointestinal ones. To remain competitive, the company must invest in R&D and regulatory approvals. This chart shows how it uses debt to fund the development of new tests and market expansion.
Market segment debt to market segment book capitalization - Medanalysis
Biomerica develops and markets diagnostic tests for various diseases. Medical diagnostics is a competitive market. This chart shows how a small company finances its research and commercialization. It compares its debt load to the overall market capitalization, reflecting its financial growth strategy.
Debt to book value of all companies in the market
Biomerica develops and markets diagnostic tests for various diseases. Medical diagnostics is a competitive market, requiring investment in R&D and marketing. Does the company use debt to expand its product line? This chart of total market debt allows us to assess the conservativeness of its financial policy.
P/E of the company, segment and market as a whole
P/E - Biomerica Inc.
Biomerica develops and markets diagnostic tests for gastrointestinal diseases and other conditions. This chart shows how investors value its products, including at-home tests. The valuation depends on regulatory approvals and the commercial success of its tests.
P/E of the market segment - Medanalysis
Biomerica develops, manufactures, and markets medical diagnostic tests for the early detection and monitoring of chronic diseases, such as gastrointestinal disorders. This chart illustrates the average rating in the medical diagnostics sector, where test accuracy, ease of use, and regulatory approval are important factors.
P/E of the market as a whole
Biomerica, Inc. develops, manufactures, and markets advanced diagnostic tests for the early detection and monitoring of chronic diseases, such as gastrointestinal diseases and diabetes. This chart reflects general trends in the healthcare sector. It helps understand whether BMRA is valued as an innovative diagnostics company or whether its value moves in line with overall market sentiment.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Biomerica Inc.
Biomerica produces and markets diagnostic tests for the early detection of various diseases, including cancer and gastrointestinal disorders. The company's growth depends on demand for affordable and rapid diagnostics. This chart shows how the market perceives the commercial potential of their testing systems and future demand for preventive medicine.
%20P%2FE%20Biomerica%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Biomerica-Inc.&v=1772634872904 "Chart of the company's future (projected) P/E Biomerica Inc.")
Future (projected) P/E of the market segment - Medanalysis
Biomerica develops and markets diagnostic tests for various diseases. Demand for fast and accurate diagnostics is constantly growing. Average profitability expectations for the segment are shown here. This allows us to assess how the market views Biomerica's product line and its ability to compete with diagnostic giants.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Medanalysis&v=1772634872916 "Future (projected) P/E graph of the market segment - Medanalysis")
Future (projected) P/E of the market as a whole
Biomerica produces diagnostic tests for various diseases, including gastrointestinal disorders. Demand for diagnostics is growing alongside the focus on preventative medicine. This chart of overall healthcare sentiment helps understand how investors view the prospects of companies operating in the medical testing market.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772634872921 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Biomerica Inc.
Biomerica, Inc. develops and markets diagnostic tests for various diseases, including gastrointestinal disorders and diabetes. The company's profits depend on sales of its tests to physicians and laboratories. This chart shows how the demand for fast and accurate diagnostics impacts the company's financial performance.
Profit of companies in the market segment - Medanalysis
Biomerica, Inc. develops and markets diagnostic tests for a variety of diseases, including gastrointestinal disorders. Accurate and timely diagnosis is key to effective treatment. This chart shows the overall profitability of the healthcare analytics sector, which is benefiting from the growing demand for personalized medicine and preventative diagnostics.
Overall market profit
Biomerica, Inc. produces diagnostic tests for various diseases. Demand for medical diagnostics is stable and driven by the needs of the healthcare system, not the state of the economy. This makes Biomerica's business resilient to recessions and fluctuations, as reflected in this chart, as health care remains a priority.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Biomerica Inc.
Biomerica develops and markets diagnostic tests for gastrointestinal diseases and other conditions. Future revenue depends on the approval of new tests and their clinical adoption. This chart shows analysts' expectations for demand for innovative and non-invasive diagnostic methods.
%20profit%20of%20the%20company%20Biomerica%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Biomerica-Inc.&v=1772634872973 "Graph of future (projected) profit of the company Biomerica Inc.")
Future (predicted) profit of companies in the market segment - Medanalysis
Biomerica develops and markets diagnostic tests for gastrointestinal diseases and other conditions. The company focuses on tests that can be administered both in the laboratory and at home. This chart shows revenue expectations for the medical diagnostics sector, helping to assess Biomerica's role in early disease detection.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Medanalysis&v=1772634873013 "Graph of future (predicted) profits of companies in a market segment - Medanalysis")
Future (predicted) profit of the market as a whole
Biomerica, Inc. develops and markets diagnostic tests for various diseases. Demand for its products depends on healthcare spending. This economic outlook is important because it impacts healthcare budgets and consumers' ability to afford diagnostic procedures.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772634873024 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Biomerica Inc.
Biomerica produces diagnostic tests for various diseases. The company's revenue depends on sales of its tests to healthcare institutions and end consumers. This chart shows how investors view its product line and its ability to compete in the medical diagnostics market.
P/S market segment - Medanalysis
Biomerica develops and markets medical diagnostic tests for the early detection and monitoring of various diseases, including gastrointestinal and oncological ones. The company's products help doctors and patients make timely decisions. This chart reflects the average revenue estimate for the sector, allowing one to assess the market perception of the commercial potential of Biomerica's tests.
P/S of the market as a whole
Biomerica develops and markets diagnostic tests for various diseases, including gastrointestinal disorders and diabetes. This chart, showing average market revenue estimates, provides insight into investor sentiment in the medical diagnostics sector, where accuracy, regulatory approvals, and commercialization are key factors.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Biomerica Inc.
Biomerica develops and markets diagnostic tests for various diseases, including gastrointestinal disorders. Estimating future revenue is important to the company. It reflects investor expectations for growing demand for its tests, both for clinical use and for home use, a key trend in modern diagnostics.
%20P%2FS%20Biomerica%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Biomerica-Inc.&v=1772634873083 "The graph of the company's future (projected) P/S Biomerica Inc.")
Future (projected) P/S of the market segment - Medanalysis
Biomerica develops and markets diagnostic tests for gastrointestinal diseases and other conditions. This chart reflects how investors view the company's future revenues relative to the medical diagnostics sector. It demonstrates the market's confidence in the accuracy of its tests and their potential for early disease detection, which could improve patient outcomes.
%20P%2FS%20market%20segment%20graph%20-%20Medanalysis&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Medanalysis&v=1772634873099 "Future (projected) P/S market segment graph - Medanalysis")
Future (projected) P/S of the market as a whole
Biomerica develops and markets diagnostic tests for gastrointestinal diseases and other conditions. The company's growth depends on demand for rapid and accurate diagnostics, including for at-home use. This graph of investor expectations reflects their confidence in the growth of the medical testing and preventive medicine market.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772634873158 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Biomerica Inc.
This chart shows Biomerica, Inc.'s revenue from diagnostic tests, including those for gastrointestinal diseases and diabetes. Revenue growth reflects demand for its products from medical laboratories and physicians, as well as the successful launch of new, more accurate and convenient diagnostic systems.
Sales of companies in the market segment - Medanalysis
Biomerica, Inc. develops and markets diagnostic tests for gastrointestinal diseases and other conditions. Its sales structure shows how much revenue comes from home tests and how much from clinical laboratory tests. This reflects its strategy for operating in different segments of the diagnostics market.
Overall market sales
Biomerica, Inc. produces diagnostic tests for various diseases. Demand for diagnostics is a vital part of the healthcare system and is often less cyclical than other sectors. This graph of overall economic activity helps assess how the sector, which focuses on early disease detection, performs amidst overall market fluctuations.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Biomerica Inc.
Biomerica, Inc. develops and commercializes medical diagnostic tests for the early detection and monitoring of various diseases, including tests for gastrointestinal diseases and cancer. Sales growth depends on the adoption of its tests in clinical practice. This chart shows analysts' forecasts for demand for the company's diagnostic products from laboratories and physicians.
%20sales%20of%20the%20company%20Biomerica%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Biomerica-Inc.&v=1772634873402 "Schedule of future (projected) sales of the company Biomerica Inc.")
Future (projected) sales of companies in the market segment - Medanalysis
Biomerica, Inc. develops and markets diagnostic tests for various diseases, including gastrointestinal ones. This chart illustrates the forecast for the medical testing market. Is the demand for rapid and accurate diagnostics for early disease detection growing? This determines the overall outlook for the industry.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Medanalysis&v=1772634873424 "Schedule of future (projected) sales of companies in the market segment - Medanalysis")
Future (projected) sales of the market as a whole
Biomerica develops and markets diagnostic tests for healthcare providers and consumers. Demand for diagnostics can be stable, but it still depends on healthcare budgets and consumer spending. This pattern of overall economic activity can influence people's willingness to spend money on optional tests or clinics' ability to purchase new equipment.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772634873437 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Biomerica Inc.
Biomerica manufactures and sells diagnostic tests for various diseases, including gastrointestinal disorders. This chart shows the company's performance in the medical diagnostics market. Its profitability depends on test sales volume, regulatory approvals, and its ability to compete with major players in the industry.
Market segment marginality - Medanalysis
Biomerica, Inc. develops and markets diagnostic tests for various diseases, including gastrointestinal disorders. The company's profitability depends on test sales volume, manufacturing efficiency, and obtaining necessary regulatory approvals. This metric reflects how the company competes in the medical diagnostics market, striving for growth and profitability.
Market marginality as a whole
Biomerica, Inc. develops and markets diagnostic tests for a variety of diseases. Demand for its products is driven by healthcare costs and the desire for early detection. This gross profitability chart reflects the state of the economy, which impacts healthcare budgets and patient affordability, shaping Biomerica's market.
Employees in the company, segment and market as a whole
Number of employees in the company Biomerica Inc.
Biomerica develops and markets diagnostic tests for gastrointestinal diseases and other conditions. Its team of scientists and manufacturing specialists is the core of its business. This chart shows how the company manages its resources to develop new tests and obtain regulatory approvals for their global sale.
Share of the company's employees Biomerica Inc. within the market segment - Medanalysis
Biomerica produces diagnostic tests for various diseases. Developing and producing medical tests is a knowledge-intensive process, requiring a team of biologists, chemists, and quality control specialists. This chart shows the company's market share in the medical diagnostics sector, reflecting its production and research capacity.
Number of employees in the market segment - Medanalysis
Biomerica manufactures and markets diagnostic tests for gastrointestinal diseases and other conditions. This chart shows employment trends in the medical analytics sector. The growing trend toward early diagnosis and at-home testing creates favorable conditions for Biomerica to expand its product line and markets.
Number of employees in the market as a whole
Biomerica develops diagnostic tests for disease detection. Demand for its products is driven by the needs of the healthcare system, not the overall economic situation. This chart shows general trends, but Biomerica represents the medical diagnostics sector, which provides stable jobs and plays a key role in disease prevention and treatment.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Biomerica Inc. (BMRA)
Biomerica produces diagnostic tests for various diseases. This business combines R&D (development of new tests) and manufacturing. This metric helps evaluate their model. It shows the market value per employee, allowing one to understand whether the market values their manufacturing efficiency or their R&D pipeline.
%20of%20the%20company%20Biomerica%20Inc.%20(BMRA)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Biomerica-Inc.-BMRA&v=1772634873589 "Chart of market capitalization per employee (in thousands of dollars) of the company Biomerica Inc. (BMRA)")
Market capitalization per employee (in thousands of dollars) in the market segment - Medanalysis
Biomerica (BMRA) produces diagnostic tests for various diseases. For companies in the medical diagnostics industry, this metric reflects both current sales and the potential for new products. Deviations from the average may be due to the launch of an innovative test that could become a standard in its field, creating significant value.
%20by%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Medanalysis&v=1772634873614 "Market capitalization per employee (in thousands of dollars) by market segment - Medanalysis")
Market capitalization per employee (in thousands of dollars) for the overall market
Biomerica produces diagnostic tests for various diseases. In the medical diagnostics sector, this metric reflects the balance between R&D and production. The market evaluates both the accuracy and demand for tests and the company's ability to efficiently produce and market them, which together determines its market value.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772634873630 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Biomerica Inc. (BMRA)
Biomerica is a company specializing in the development of diagnostic tests (for example, for gastrointestinal diseases). This chart shows the profitability of producing and selling these tests. Profit per employee here is the balance between R&D costs (developing new tests) and the margin earned from the sale of each diagnostic kit.
%20Chart%20Biomerica%20Inc.%20(BMRA)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Biomerica-Inc.-BMRA&v=1772634873654 "Company Profit Per Employee (in thousands of dollars) Chart Biomerica Inc. (BMRA)")
Profit per employee (in thousands of dollars) in the market segment - Medanalysis
Biomerica, Inc. produces diagnostic tests for medical institutions and home use. In the medical device industry, employee efficiency depends on automated production and distribution. This graph shows the profit generated by each employee, allowing one to evaluate the company's operational efficiency compared to competitors in the diagnostics market.
%20in%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Medanalysis&v=1772634873676 "Chart of profit per employee (in thousands of dollars) in the market segment - Medanalysis")
Profit per employee (in thousands of dollars) for the market as a whole
Biomerica is a company specializing in medical diagnostics. They produce rapid (in vitro) tests for detecting various diseases, including gastrointestinal diseases. This is a medtech business that requires R&D, quality control, and production lines. This chart allows you to evaluate how profitable diagnostic test production is per employee compared to the overall economy.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772634873693 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Biomerica Inc. (BMRA)
Biomerica develops and markets diagnostic tests. This chart shows the efficiency of their manufacturing and commercial operations. The increase in revenue per employee can be attributed to automation of production, approval of new tests, and expansion of the distribution network both in the US and internationally.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Biomerica-Inc.-BMRA&v=1772634873708 "Sales chart per company employee Biomerica Inc. (BMRA)")
Sales per employee in the market segment - Medanalysis
Biomerica produces diagnostic tests, including for gastrointestinal diseases (such as IBS) and COVID-19 tests. It's a medtech (diagnostics) company. This chart shows the average output in the sector. For BMRA, this is an indicator: how productive are their manufacturing and R&D efforts in creating and selling these medical tests compared to diagnostics giants?
Sales per employee for the market as a whole
Biomerica is a company specializing in the production of diagnostic tests, primarily for gastrointestinal diseases. Their business encompasses R&D, manufacturing, and sales of medical kits. This indicator demonstrates how effectively their production lines and sales team are able to deliver these relatively inexpensive yet in-demand tests to the market.
Short shares by company, segment and market as a whole
Shares shorted by company Biomerica Inc. (BMRA)
Biomerica (BMRA) develops and sells diagnostic tests, including for gastrointestinal diseases and COVID-19. The diagnostics market has become crowded. This chart shows the number of shares borrowed for short sale. Bears may believe that demand for tests (especially for COVID) has fallen, and the company's new products will not be widely adopted due to intense competition.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Biomerica-Inc.-BMRA&v=1772634873754 "Short Shares Chart for the Company Biomerica Inc. (BMRA)")
Shares shorted by market segment - Medanalysis
Biomerica (BMRA) specializes in the development and sale of diagnostic tests, particularly for gastrointestinal diseases. This chart shows the total short position in the medical diagnostics sector. It reflects investor skepticism about this segment following the pandemic, with expectations of a decline in demand and pricing pressure.
Shares shorted by the overall market
Biomerica (BMRA) is a diagnostics company. When this fear indicator rises, investors fear that in a recession (1) patients will refuse "optional" tests and (2) the volume of routine testing will decline. Investors are selling small, complex stories.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Biomerica Inc. (BMRA)
Biomerica (BMRA) produces diagnostic tests, including for gastrointestinal diseases and COVID-19. Demand for diagnostics can be volatile. This indicator measures the strength of price movements. It shows when shares are "overheated" (above 70) on news of disease outbreaks or "oversold" (below 30) during periods of calm or increased competition.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Biomerica-Inc.-BMRA&v=1772634873911 "RSI 14 indicator chart for the company's stock Biomerica Inc. (BMRA)")
RSI 14 Market Segment - Medanalysis
Biomerica is a company specializing in the development and sale of medical diagnostic tests, including those for gastrointestinal diseases (GI diseases) and rapid diagnostic tests. This chart shows the overall sentiment in the medical diagnostics and testing sector. It helps understand how investors view the industry and how Biomerica compares to its competitors.
RSI 14 for the overall market
For Biomerica (BMRA), a diagnostic testing company, this chart is a two-pronged indicator. During periods of market euphoria, its core business is stable. However, market panic associated with the threat of a pandemic (like COVID-19) can trigger an explosive increase in demand for its products, making it a "safe haven" asset.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast BMRA (Biomerica Inc.)
Biomerica is a company that develops and markets diagnostic tests for gastrointestinal diseases (IBS test) and cancer. This chart shows the average analyst forecast. Their targets are based on test sales growth, FDA approvals, and successful distribution agreements.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-BMRA-Biomerica-Inc.&v=1772634874078 "A chart showing analyst consensus forecasts for the expected stock price. BMRA (Biomerica Inc.)")
The difference between the consensus estimate and the actual stock price BMRA (Biomerica Inc.)
Biomerica is a company specializing in the development and sale of rapid diagnostic tests, including those for gastrointestinal diseases (IBS). This chart illustrates the analyst community's opinion on the company's future. It measures the distance between the stock price and the target, reflecting their belief in the commercial success of their diagnostic products.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-BMRA-Biomerica-Inc.&v=1772634874087 "A chart showing the difference between the consensus forecast and the actual stock price. BMRA (Biomerica Inc.)")
Analyst consensus forecast for stock prices by market segment - Medanalysis
Biomerica is a diagnostics veteran. The company produces simple and rapid in-vitro tests for gastrointestinal diseases and allergies, sold to physicians and consumers. This chart shows analysts' overall expectations for the medical testing sector. It reflects whether experts believe the market for rapid at-home diagnostics will grow.
Analysts' consensus forecast for the overall market share price
Biomerica (BMRA) is a company specializing in at-home diagnostics. They produce tests for gastrointestinal disorders (IBS, celiac disease). They're betting on "patient-centered" medicine. This chart shows the general sentiment of experts. It reflects analysts' confidence in the stability of consumer spending on wellness and health products.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Biomerica Inc.
Biomerica is an at-home diagnostics company. They produce tests (primarily for the gastrointestinal tract) that allow patients (or doctors) to non-invasively (without endoscopy) diagnose problems such as IBS (irritable bowel syndrome) or H. pylori. This chart summarizes their implementation history and reflects their (slow) progress toward receiving reimbursement from insurance companies.
AKIMA Market Segment Index - Medanalysis
Biomerica (BMRA) is a company specializing in diagnostic testing. Their primary focus is gastrointestinal disorders (gastroenterology). They produce tests (including InFoods for IBS) that help identify food intolerances and other disorders. This chart shows the average index for the segment. It helps assess how successful BMRA is in its niche compared to the average.
The AKIM Index for the overall market
Biomerica is a manufacturer of diagnostic tests for diseases and food intolerances (inFoods). This chart, reflecting the market average, is a backdrop. It helps assess how this niche MedTech business, focused on gut health, stacks up against the backdrop of overall macroeconomic fluctuations.
